Nocturnal hemodialysis: Effects on solute clearance, quality of life, and patient survival

Current Opinion in Nephrology and Hypertension

Volumn 20, Issue 2, 2011, Pages 182-188

  McFarlane, Philip A ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

hemodialysis; nocturnal; quality of life; survival; uremia

Indexed keywords

BETA 2 MICROGLOBULIN; PHOSPHATE BINDING AGENT; UREA;

ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; COST MINIMIZATION ANALYSIS; COST OF ILLNESS; DIALYSATE; EVENT FREE SURVIVAL; GLOMERULUS FILTRATION RATE; GRAFT RECIPIENT; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEMODIALYSIS; HEMODIALYSIS PATIENT; HOME DIALYSIS; HOSPITAL ADMISSION; HUMAN; KIDNEY CLEARANCE; KIDNEY DISEASE; KIDNEY GRAFT; LIVING DONOR; MORTALITY; NOCTURNAL HEMODIALYSIS; NURSE PATIENT RATIO; PREDICTION; PRIORITY JOURNAL; QUALITY OF LIFE; SLEEP APNEA SYNDROME; SODIUM RETENTION; SURVIVAL RATE; TREATMENT DURATION; UREA BLOOD LEVEL; UREMIA; WATER RETENTION;

HUMANS; KIDNEY FAILURE, CHRONIC; METABOLIC CLEARANCE RATE; QUALITY OF LIFE; RENAL DIALYSIS; TIME FACTORS;

EID: 79952043137     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/MNH.0b013e3283437046     Document Type: Article

References (65)

1. Rioux JP, Chan CT. Nocturnal home hemodialysis and its impact on erythropoietin responsiveness. Clin Nephrol 2010; 74:167-172.
2. Basile C, Libutti P, Di Turo AL, et al. Haemodynamic stability in standard bicarbonate haemodialysis and long-hour slow-flow bicarbonate haemodialysis. Nephrol Dialysis Transplant 2011; 26:252-258.
3. Luik AJ, Charra B, Katzarski K, et al. Blood pressure control and hemodynamic changes in patients on long time dialysis treatment. Blood Purif 1998; 16:197-209. (Pubitemid 28458432)
4. Pierratos A. Nocturnal home haemodialysis: an update on a 5-year experience. Nephrol Dial Transplant 1999; 14:2835-2840.
5. Hanly PJ, Pierratos A. Improvement of sleep apnea in patients with chronic renal failure who undergo nocturnal hemodialysis. N Engl J Med 2001; 344:102-107. (Pubitemid 32052499)
6. Lindsay RM, Alhejaili F, Nesrallah G, et al. Calcium and phosphate balance with quotidian hemodialysis. Am J Kidney Dis 2003; 42:24-29.
7. Pierratos A, Hercz G, Sherrard DJ, et al. Calcium, phosphorus metabolism and bone pathology on long term nocturnal hemodialysis. J Am Soc Nephrol 2001; 12:274A.
8. Walsh M, Manns BJ, Klarenbach S, et al. The effects of nocturnal compared with conventional hemodialysis on mineral metabolism: a randomized-controlled trial. Hemodial Int 2009; 14:174-181.
9. Barua M, Hladunewich M, Keunen J, et al. Successful pregnancies on nocturnal home hemodialysis. Clin J Am Soc Nephrol 2008; 3:392-396.
10. Almeras C, Argilés À . The general picture of uremia. Semin Dial 2009; 22:329-333.
11. Piorry P. Traité d'alterations du sang. Bailliere, Paris, France, 1840.
12. Pierratos A. Effect of therapy time and frequency on effective solute removal. Semin Dial 2001; 14:284-288. (Pubitemid 33720865)
13. Vanholder R, De Smet R, Glorieux G, et al. Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int 2003; 63:1934-1943. (Pubitemid 36513344)
14. McFarlane PA. More of the same: improving outcomes through intensive hemodialysis. Semin Dial 2009; 22:598-602.
15. Bell CM, Chapman RH, Stone PW, et al. An off-the-shelf help list: a comprehensive catalog of preference scores from published cost-utility analyses. Medical Decis Making 2001; 21:288-294. (Pubitemid 32652492)
16. McFarlane PA, Bayoumi AM, Pierratos A, et al. The quality of life and cost utility of home nocturnal and conventional in-center hemodialysis. Kidney Int 2003; 64:1004-1011. (Pubitemid 37013836)
17. Canadian Institute For Health Information: 2007 Annual Report -Treatment of End-Stage Organ Failure in Canada, 1996 to 2005. Ottawa, Canada; 2008.
18. The United States Renal Data System: overall hospitalization and mortality. Am J Kidney Dis 2003; 42:S136-S140.
19. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998; 32:S112-119. (Pubitemid 28527268)
20. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for 2006 Updates: hemodialysis adequacy, peritoneal dialysis adequacy and vascular access. Am J Kidney Dis 2006; 48:S1-S322.
21. Gotch FA. The current place of urea kinetic modelling with respect to different dialysis modalities. Nephrol Dial Transplant 1998; 13:10-14. (Pubitemid 28356684)
22. Johnson WJ, Hagge WW, Wagoner RD, et al. Effects of urea loading in patients with far-advanced renal failure. Mayo Clin Proc 1972; 47:21-29.
23. Basile C, Libutti P, Di Turo AL, et al. Removal of uraemic retention solutes in standard bicarbonate haemodialysis and long-hour slow-flow bicarbonate haemodialysis. Nephrol Dial Transplant 2010. [Epub ahead of print]
24. Charra B, Laurent G, Chazot C, et al. Clinical assessment of dry weight. Nephrol Dial Transplant 1996; 11 (Suppl 2):16-19. (Pubitemid 26182537)
25. Fishbane S, Natke E, Maesaka JK. Role of volume overload in dialysisrefractory hypertension. Am J Kidney Dis 1996; 28:257-261. (Pubitemid 26286662)
26. Wizemann V, Wabel P, Chamney P, et al. The mortality risk of overhydration in haemodialysis patients. Nephrol Dial Transplant 2009; 24:1574-1579.
27. New developments with artificial kidney. Br Med J 1963; 1:1685-1686.
28. Eschbach JW Jr, Wilson WE Jr, Peoples RW, et al. Unattended overnight home hemodialysis. Trans Am Soc Artif Intern Organs 1966; 12:346-356.
29. Laurent G, Charra B. The results of an 8 h thrice weekly haemodialysis schedule. Nephrol Dial Transplant 1998; 13 (Suppl 6):125-131. (Pubitemid 28356706)
30. Deziel C. Rediscovering long duration hemodialysis. Nephrol News Issues 1997; 11:41-42.
31. Johansen KL, Zhang R, Huang Y, et al. Survival and hospitalization among patients using nocturnal and short daily compared to conventional hemodialysis: a USRDS study. Kidney Int 2009; 76:984-990.
32. Nesrallah GE, Moist LM, Awaraji C, et al. An international registry to compare quotidian dialysis regimens with conventional thrice-weekly hemodialysis: why, how, and potential pitfalls. Semin Dial 2004; 17:131-135. (Pubitemid 38560985)
33. Kuhlmann MK. Phosphate elimination in modalities of hemodialysis and peritoneal dialysis. Blood Purif 2010; 29:137-144.
34. Bugeja A, Dacouris N, Thomas A, et al. In-center nocturnal hemodialysis: another option in the management of chronic kidney disease. Clin J Am Soc Nephrol 2009; 4:778-783.
35. Powell JR, Oluwaseun O, Woo YM, et al. Ten years experience of in-center thrice weekly long overnight hemodialysis. Clin J Am Soc Nephrol 2009; 4:1097-1101.
36. Lacson E, Wang W, Lester K, et al. Outcomes associated with in-center nocturnal hemodialysis from a large multicenter program. Clin J Am Soc Nephrol 2009; 5:220-226.
37. Suri R, Depner TA, Blake PG, et al. Adequacy of quotidian hemodialysis. Am J Kidney Dis 2003; 42:42-48.
38. Pierratos A, McFarlane P, Chan CT. Quotidian dialysis: update 2005. Curr Opin Nephrol Hypertens 2005; 14:119-124.
39. Gotch FA. Definitions of dialysis dose suitable for comparison of daily hemodialysis and continuous ambulatory peritoneal dialysis to conventional thrice weekly dialysis therapy. Hemodial Int 2004; 8:172-182. (Pubitemid 41025010)
40. Daugirdas JT, Depner TA, Greene T, et al. Effects of reduced intradialytic urea generation rate and residual renal clearance on modeled urea distribution volume and Kt/V in conventional, daily, and nocturnal dialysis. Semin Dial 2010; 23:19-24.
41. Gutzwiller JP, Schneditz D, Huber AR, et al. Increasing blood flow increases kt/V(urea) and potassium removal but fails to improve phosphate removal. Clin Nephrol 2003; 59:130-136. (Pubitemid 36221748)
42. Tonelli M, Wang W, Hemmelgarn B, et al. Phosphate removal with several thrice-weekly dialysis methods in overweight hemodialysis patients. Am J Kidney Dis 2009; 54:1108-1115.
43. Eloot S, Van Biesen W, Dhondt A, et al. Impact of hemodialysis duration on the removal of uremic retention solutes. Kidney Int 2007; 73:765-770.
44. Gotch FA, Panlilio F, Sergeyeva O, et al. A kinetic model of inorganic phosphorus mass balance in hemodialysis therapy. Blood Purif 2003; 21:51-57. (Pubitemid 36173349)
45. DeSoi CA, Umans JG. Phosphate kinetics during high-flux hemodialysis. J Am Soc Nephrol 1993; 4:1214-1218.
46. Spalding EM, Chamney PW, Farrington K. Phosphate kinetics during hemodialysis: evidence for biphasic regulation. Kidney Int 2002; 61:655-667. (Pubitemid 34102609)
47. Mucsi I, Hercz G, Uldall R, et al. Control of serum phosphate without any phosphate binders in patients treated with nocturnal hemodialysis. Kidney Int 1998; 53:1399-1404. (Pubitemid 28316904)
48. Culleton BF, Walsh M, Klarenbach SW, et al. Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial. JAMA 2007; 298:1291-1299. (Pubitemid 47443343)
49. Schorr M, Manns BJ, Culleton B, et al. The effect of nocturnal and conventional hemodialysis on markers of nutritional status: results from a randomized trial. J Ren Nutr 2010. [Epub ahead of print].
50. Laupacis A, Keown P, Pus N, et al. A study of the quality of life and cost-utility of renal transplantation. Kidney Int 1996; 50:235-242. (Pubitemid 26323718)
51. McFarlane PA. Should patients remain on intensive hemodialysis rather than choosing to receive a kidney transplant? Semin Dial 2010; 23:516-519.
52. Heidenheim AP, Muirhead N, Moist L, et al. Patient quality of life on quotidian hemodialysis. Am J Kidney Dis 2003; 42:36-41.
53. Manns BJ, Walsh MW, Culleton BF, et al. Nocturnal hemodialysis does not improve overall measures of quality of life compared to conventional hemodialysis. Kidney Int 2009; 75:542-549.
54. McFarlane PA. Estimating preference scores in conventional and home nocturnal hemodialysis patients. Clin J Am Soc Nephrol 2007; 2:477-483.
55. Innes A, Charra B, Burden RP, et al. The effect of long, slow haemodialysis on patient survival. Nephrol Dial Transplant 1999; 14:919-922. (Pubitemid 29155147)
56. Pauly RP, Maximova K, Coppens J, et al. Patient and technique survival among a Canadian multicenter nocturnal home hemodialysis cohort. Clin J Am Soc Nephrol 2010; 5:1815-1820.
57. Pauly RP, Gill JS, Rose CL, et al. Survival among nocturnal home haemodialysis patients compared to kidney transplant recipients. Nephrol Dial Transplant 2009; 24:2915-2919.
58. Wolfe RA, Ashby VB, Milford EL, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999; 341:1725-1730.
59. Silberberg JS, Barre PE, Prichard SS, et al. Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int 1989; 36:286-290. (Pubitemid 19202488)
60. Zoccali C, Benedetto FA, Mallamaci F, et al. Left ventricular mass monitoring in the follow-up of dialysis patients: prognostic value of left ventricular hypertrophy progression. Kidney Int 2004; 65:1492-1498. (Pubitemid 38406992)
61. Laupacis A, Feeny D, Detsky AS, et al. How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations [see comments]. CMAJ 1992; 146:473-481.
62. McFarlane PA. Interpreting cost-effectiveness in dialysis: can the most expensive be more expensive? Kidney Int 2006; 69:2120-2121. (Pubitemid 43882097)
63. McFarlane PA, Pierratos A, Redelmeier DA. Cost savings of home nocturnal versus conventional in-center hemodialysis. Kidney Int 2002; 62:2216-2222. (Pubitemid 35366178)
64. Lee H, Manns B, Taub K, et al. Cost analysis of ongoing care of patients with end-stage renal disease: the impact of dialysis modality and dialysis access. Am J Kidney Dis 2002; 40:611-622. (Pubitemid 34971291)
65. McFarlane PA. Reducing hemodialysis costs: conventional and quotidian home hemodialysis in Canada. Semin Dial 2004; 17:118-124. (Pubitemid 38560983)